|
chr22_+_29876180
|
2.108
|
NM_021076
|
NEFH
|
neurofilament, heavy polypeptide
|
|
chrX_+_37545008
|
2.063
|
NM_021083
|
XK
|
X-linked Kx blood group (McLeod syndrome)
|
|
chr8_-_108510094
|
1.956
|
NM_001146
NM_001199859
|
ANGPT1
|
angiopoietin 1
|
|
chr7_+_106685007
|
1.857
|
NM_002736
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
chr15_-_83240499
|
1.630
|
NM_001079533
NM_001079534
NM_001079535
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
chrX_+_51486479
|
1.553
|
NM_018094
|
GSPT2
|
G1 to S phase transition 2
|
|
chr3_-_45267068
|
1.505
|
|
TMEM158
|
transmembrane protein 158 (gene/pseudogene)
|
|
chr16_+_2039945
|
1.489
|
NM_004209
|
SYNGR3
|
synaptogyrin 3
|
|
chr11_-_10830034
|
1.473
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
chr17_-_28619183
|
1.209
|
NM_000386
|
BLMH
|
bleomycin hydrolase
|
|
chr19_-_59069747
|
1.009
|
|
UBE2M
|
ubiquitin-conjugating enzyme E2M
|
|
chrX_-_137793826
|
0.970
|
NM_004114
|
FGF13
|
fibroblast growth factor 13
|
|
chr7_+_116139619
|
0.965
|
NM_001206747
NM_001233
NM_198212
|
CAV2
|
caveolin 2
|
|
chr10_-_52383611
|
0.958
|
NM_147156
|
SGMS1
|
sphingomyelin synthase 1
|
|
chr15_-_48937068
|
0.941
|
|
FBN1
|
fibrillin 1
|
|
chr5_+_61602236
|
0.932
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
chr1_-_167906277
|
0.921
|
NM_001143674
NM_015415
|
BRP44
|
brain protein 44
|
|
chr1_-_32403975
|
0.916
|
NM_080391
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2
|
|
chr6_+_135502477
|
0.900
|
|
MYB
|
v-myb myeloblastosis viral oncogene homolog (avian)
|
|
chr8_+_106331146
|
0.889
|
NM_012082
|
ZFPM2
|
zinc finger protein, multitype 2
|
|
chr6_+_16129321
|
0.888
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
chr4_+_174292100
|
0.876
|
|
SAP30
|
Sin3A-associated protein, 30kDa
|
|
chr5_+_95067511
|
0.872
|
|
|
|
|
chr4_+_174292027
|
0.868
|
NM_003864
|
SAP30
|
Sin3A-associated protein, 30kDa
|
|
chr17_-_28618836
|
0.858
|
|
BLMH
|
bleomycin hydrolase
|
|
chr6_+_163835668
|
0.852
|
NM_006775
NM_206853
NM_206854
NM_206855
|
QKI
|
QKI, KH domain containing, RNA binding
|
|
chr8_+_21777165
|
0.852
|
NM_015024
|
XPO7
|
exportin 7
|
|
chr15_+_43809805
|
0.850
|
NM_002373
|
MAP1A
|
microtubule-associated protein 1A
|
|
chr6_-_84140758
|
0.844
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
chr11_-_10830452
|
0.831
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
chr17_-_46703613
|
0.826
|
NM_024017
|
HOXB9
|
homeobox B9
|
|
chr5_+_61602065
|
0.806
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
chr6_+_99282597
|
0.790
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
chr5_-_88199868
|
0.775
|
NM_001131005
NM_001193347
|
MEF2C
|
myocyte enhancer factor 2C
|
|
chrX_+_30265270
|
0.767
|
NM_177404
|
MAGEB1
|
melanoma antigen family B, 1
|
|
chr17_+_30771520
|
0.766
|
|
PSMD11
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11
|
|
chr2_+_30454396
|
0.764
|
NM_030915
|
LBH
|
limb bud and heart development homolog (mouse)
|
|
chr5_+_141348646
|
0.760
|
|
RNF14
|
ring finger protein 14
|
|
chr18_+_9708322
|
0.757
|
|
RAB31
|
RAB31, member RAS oncogene family
|
|
chr1_-_32403888
|
0.751
|
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2
|
|
chr11_-_10830299
|
0.746
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
chr22_+_21213350
|
0.740
|
|
SNAP29
|
synaptosomal-associated protein, 29kDa
|
|
chr11_-_35547144
|
0.738
|
NM_001001991
NM_015430
|
PAMR1
|
peptidase domain containing associated with muscle regeneration 1
|
|
chr15_+_74218962
|
0.733
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
chr1_-_147931877
|
0.727
|
|
FLJ39739
|
uncharacterized FLJ39739
|
|
chr12_+_26348488
|
0.727
|
NM_005086
|
SSPN
|
sarcospan (Kras oncogene-associated gene)
|
|
chr5_+_141348692
|
0.715
|
NM_183401
|
RNF14
|
ring finger protein 14
|
|
chr2_+_127413739
|
0.709
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
chr16_+_222845
|
0.707
|
NM_000517
|
HBA1
HBA2
|
hemoglobin, alpha 1
hemoglobin, alpha 2
|
|
chr7_+_116140097
|
0.707
|
NM_001206748
|
CAV2
|
caveolin 2
|
|
chr8_+_21777216
|
0.706
|
|
XPO7
|
exportin 7
|
|
chr6_+_16143281
|
0.700
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
chr1_-_144520918
|
0.688
|
|
LOC728855
|
uncharacterized LOC728855
|
|
chr11_-_33891258
|
0.682
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
chr6_+_135502445
|
0.678
|
NM_001130172
NM_001130173
NM_001161656
NM_001161657
NM_001161658
NM_001161659
NM_001161660
NM_005375
|
MYB
|
v-myb myeloblastosis viral oncogene homolog (avian)
|
|
chr15_-_83316621
|
0.671
|
NM_030594
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
chr11_-_33891485
|
0.671
|
NM_001142315
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
chr12_+_56137063
|
0.668
|
NM_005811
|
GDF11
|
growth differentiation factor 11
|
|
chr2_+_105471745
|
0.660
|
NM_006236
|
POU3F3
|
POU class 3 homeobox 3
|
|
chr11_-_32457059
|
0.659
|
NM_000378
NM_024424
NM_024426
|
WT1
|
Wilms tumor 1
|
|
chr11_-_111782447
|
0.656
|
NM_001885
|
CRYAB
|
crystallin, alpha B
|
|
chr11_-_67188614
|
0.641
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
chr3_+_142838596
|
0.640
|
NM_004267
|
CHST2
|
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2
|
|
chr16_+_226678
|
0.625
|
NM_000558
|
HBA1
HBA2
|
hemoglobin, alpha 1
hemoglobin, alpha 2
|
|
chr7_-_150754934
|
0.618
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
chr1_+_41445402
|
0.617
|
|
CTPS
|
CTP synthase
|
|
chr5_+_176560056
|
0.616
|
NM_172349
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
chr15_-_35087748
|
0.614
|
NM_005159
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
chr1_-_144931967
|
0.612
|
NM_001002811
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
chr4_-_73434467
|
0.608
|
NM_014243
|
ADAMTS3
|
ADAM metallopeptidase with thrombospondin type 1 motif, 3
|
|
chr1_+_51434231
|
0.607
|
NM_001262
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
chr5_+_119800004
|
0.601
|
NM_016644
|
PRR16
|
proline rich 16
|
|
chrX_+_153672490
|
0.599
|
|
FAM50A
|
family with sequence similarity 50, member A
|
|
chr5_+_61601944
|
0.599
|
NM_001098511
NM_001243952
NM_001243953
NM_004520
|
KIF2A
|
kinesin heavy chain member 2A
|
|
chr3_-_15900928
|
0.599
|
NM_015199
|
ANKRD28
|
ankyrin repeat domain 28
|
|
chr8_+_37654757
|
0.594
|
|
GPR124
|
G protein-coupled receptor 124
|
|
chr8_+_37654395
|
0.592
|
NM_032777
|
GPR124
|
G protein-coupled receptor 124
|
|
chrX_-_138287180
|
0.592
|
NM_001139498
NM_001139500
NM_001139501
|
FGF13
|
fibroblast growth factor 13
|
|
chr6_-_26056647
|
0.581
|
NM_005319
|
HIST1H1C
|
histone cluster 1, H1c
|
|
chr6_+_150070856
|
0.580
|
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
chr17_+_39240412
|
0.578
|
NM_033061
|
KRTAP4-7
|
keratin associated protein 4-7
|
|
chr3_+_43732358
|
0.577
|
NM_016006
|
ABHD5
|
abhydrolase domain containing 5
|
|
chr5_+_36152142
|
0.577
|
NM_001243120
NM_005983
NM_032637
|
SKP2
|
S-phase kinase-associated protein 2 (p45)
|
|
chr5_+_141348450
|
0.575
|
NM_004290
NM_183398
NM_183400
|
RNF14
|
ring finger protein 14
|
|
chr8_+_37654406
|
0.569
|
|
GPR124
|
G protein-coupled receptor 124
|
|
chr2_+_198669316
|
0.568
|
NM_006226
|
PLCL1
|
phospholipase C-like 1
|
|
chr16_-_103557
|
0.567
|
NM_016310
|
POLR3K
|
polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa
|
|
chr7_-_150754979
|
0.565
|
NM_001164410
NM_004935
|
CDK5
|
cyclin-dependent kinase 5
|
|
chr7_-_128045995
|
0.559
|
NM_001142573
NM_001142574
NM_001142575
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
chr2_+_127413678
|
0.559
|
NM_002101
NM_016815
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
chr12_+_69633352
|
0.557
|
|
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa
|
|
chr1_-_44820935
|
0.557
|
NM_024066
|
ERI3
|
ERI1 exoribonuclease family member 3
|
|
chr3_-_160283166
|
0.556
|
|
KPNA4
|
karyopherin alpha 4 (importin alpha 3)
|
|
chr5_+_118691549
|
0.553
|
NM_014350
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8
|
|
chr5_+_119799898
|
0.553
|
|
PRR16
|
proline rich 16
|
|
chr22_-_22221937
|
0.552
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
chr8_-_101964236
|
0.547
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
|
|
chr2_+_113033146
|
0.544
|
NM_198581
|
ZC3H6
|
zinc finger CCCH-type containing 6
|
|
chr9_+_131451847
|
0.542
|
|
SET
|
SET nuclear oncogene
|
|
chr6_+_150070844
|
0.542
|
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
chr5_+_141348731
|
0.534
|
|
RNF14
|
ring finger protein 14
|
|
chr6_+_150070818
|
0.533
|
NM_001252049
NM_001252050
NM_001252051
NM_001252052
NM_001252053
NM_005389
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
chr1_+_84944919
|
0.532
|
NM_025065
|
RPF1
|
ribosome production factor 1 homolog (S. cerevisiae)
|
|
chr16_-_65155984
|
0.532
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
chr16_+_23847359
|
0.531
|
|
PRKCB
|
protein kinase C, beta
|
|
chr11_+_20385259
|
0.528
|
NM_001098520
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
chr5_+_139493689
|
0.526
|
NM_005859
|
PURA
|
purine-rich element binding protein A
|
|
chr1_+_41445359
|
0.522
|
|
CTPS
|
CTP synthase
|
|
chr2_-_157189040
|
0.517
|
NM_006186
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
chr5_+_176560627
|
0.514
|
NM_022455
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
chr17_+_59477169
|
0.506
|
NM_005994
|
TBX2
|
T-box 2
|
|
chr1_-_44820939
|
0.500
|
|
ERI3
|
ERI1 exoribonuclease family member 3
|
|
chr4_-_83350452
|
0.500
|
|
HNRPDL
|
heterogeneous nuclear ribonucleoprotein D-like
|
|
chr7_-_150945731
|
0.498
|
NM_001003801
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
chr19_-_13213669
|
0.497
|
|
LYL1
|
lymphoblastic leukemia derived sequence 1
|
|
chr20_+_31350190
|
0.496
|
NM_001207055
NM_001207056
NM_006892
NM_175848
NM_175849
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
chr2_+_189156395
|
0.492
|
NM_001252668
NM_001252669
NM_016315
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1
|
|
chr12_+_26348268
|
0.488
|
NM_001135823
|
SSPN
|
sarcospan (Kras oncogene-associated gene)
|
|
chr8_+_64081108
|
0.486
|
NM_152758
|
YTHDF3
|
YTH domain family, member 3
|
|
chr15_-_55581969
|
0.484
|
NM_183235
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
chr1_-_167905214
|
0.484
|
|
BRP44
|
brain protein 44
|
|
chr22_-_22221953
|
0.481
|
NM_002745
NM_138957
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
chr12_-_42631982
|
0.481
|
NM_001190977
|
YAF2
|
YY1 associated factor 2
|
|
chr1_-_6295989
|
0.475
|
|
ICMT
|
isoprenylcysteine carboxyl methyltransferase
|
|
chr1_-_143744355
|
0.475
|
|
LOC100286793
FLJ39739
|
uncharacterized LOC100286793
uncharacterized FLJ39739
|
|
chr6_-_27114577
|
0.474
|
NM_080593
|
HIST1H2BK
|
histone cluster 1, H2bk
|
|
chr1_-_245027808
|
0.473
|
NM_004501
NM_031844
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
chr1_-_200379165
|
0.469
|
NM_012482
|
ZNF281
|
zinc finger protein 281
|
|
chr10_+_17271341
|
0.468
|
|
VIM
|
vimentin
|
|
chr19_+_46850245
|
0.468
|
NM_001204284
NM_006247
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
chr1_-_167905078
|
0.468
|
|
BRP44
|
brain protein 44
|
|
chr4_+_110481315
|
0.468
|
NM_017918
|
CCDC109B
|
coiled-coil domain containing 109B
|
|
chr11_-_10879365
|
0.465
|
NM_001143667
NM_021211
|
ZBED5
|
zinc finger, BED-type containing 5
|
|
chr11_+_65658101
|
0.465
|
|
CCDC85B
|
coiled-coil domain containing 85B
|
|
chr2_+_114647699
|
0.464
|
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast)
|
|
chr19_+_11649578
|
0.463
|
NM_001299
|
CNN1
|
calponin 1, basic, smooth muscle
|
|
chr1_-_144521169
|
0.462
|
|
FAM91A2
|
family with sequence similarity 91, member A2
|
|
chr16_+_23847271
|
0.460
|
NM_002738
NM_212535
|
PRKCB
|
protein kinase C, beta
|
|
chr6_-_111804413
|
0.458
|
NM_002912
|
REV3L
|
REV3-like, catalytic subunit of DNA polymerase zeta (yeast)
|
|
chr3_-_122233764
|
0.454
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
chr10_+_17271859
|
0.454
|
|
VIM
|
vimentin
|
|
chr14_-_21994342
|
0.449
|
|
SALL2
|
sal-like 2 (Drosophila)
|
|
chr2_+_12856813
|
0.448
|
NM_021643
|
TRIB2
|
tribbles homolog 2 (Drosophila)
|
|
chr10_+_17271276
|
0.446
|
|
VIM
|
vimentin
|
|
chr7_+_116593554
|
0.446
|
|
ST7
|
suppression of tumorigenicity 7
|
|
chr1_-_245027610
|
0.446
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
chr10_+_17271956
|
0.444
|
|
VIM
|
vimentin
|
|
chr12_+_62654120
|
0.444
|
NM_001252078
NM_001252079
NM_006313
|
USP15
|
ubiquitin specific peptidase 15
|
|
chr10_+_17271302
|
0.444
|
|
VIM
|
vimentin
|
|
chr17_+_40610897
|
0.444
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
chr17_-_42296923
|
0.442
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
chr22_-_22221722
|
0.442
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
chr5_+_36152221
|
0.442
|
|
SKP2
|
S-phase kinase-associated protein 2 (p45)
|
|
chr10_+_17271277
|
0.441
|
|
VIM
|
vimentin
|
|
chr7_-_2883649
|
0.438
|
NM_007353
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
chr4_-_111544206
|
0.436
|
NM_000325
|
PITX2
|
paired-like homeodomain 2
|
|
chr11_+_10772781
|
0.435
|
NM_014633
|
CTR9
|
Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
|
|
chr1_-_31845818
|
0.435
|
NM_004102
|
FABP3
|
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
|
|
chr1_-_144520987
|
0.432
|
|
LOC728855
|
uncharacterized LOC728855
|
|
chr3_+_20081853
|
0.432
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
chr2_+_189156603
|
0.431
|
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1
|
|
chr1_-_144931707
|
0.429
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
chr12_+_54378929
|
0.428
|
NM_017409
|
HOXC10
|
homeobox C10
|
|
chr15_-_37391596
|
0.427
|
NM_172316
|
MEIS2
|
Meis homeobox 2
|
|
chr16_-_12009568
|
0.426
|
|
|
|
|
chr11_-_32456910
|
0.425
|
|
WT1
|
Wilms tumor 1
|
|
chr1_-_6296034
|
0.425
|
NM_012405
|
ICMT
|
isoprenylcysteine carboxyl methyltransferase
|
|
chrX_-_109561298
|
0.421
|
|
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1
|
|
chr18_+_9708269
|
0.421
|
|
RAB31
|
RAB31, member RAS oncogene family
|
|
chr6_-_139695349
|
0.419
|
NM_001168389
NM_001168388
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
chr15_-_69113213
|
0.419
|
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
|
chr14_+_33408458
|
0.419
|
NM_001164749
NM_001165893
NM_022123
NM_173159
|
NPAS3
|
neuronal PAS domain protein 3
|
|
chr3_-_45017600
|
0.418
|
NM_001135179
NM_016598
|
ZDHHC3
|
zinc finger, DHHC-type containing 3
|
|
chr3_+_150321065
|
0.417
|
NM_016275
|
SELT
|
selenoprotein T
|
|
chr16_-_69364436
|
0.416
|
NM_022341
|
PDF
|
peptide deformylase (mitochondrial)
|
|
chr13_-_103426075
|
0.416
|
|
C13orf27
|
chromosome 13 open reading frame 27
|
|
chr3_-_160283071
|
0.415
|
|
KPNA4
|
karyopherin alpha 4 (importin alpha 3)
|
|
chr20_-_32031425
|
0.414
|
NM_003098
|
SNTA1
|
syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)
|
|
chr14_+_50087400
|
0.414
|
NM_002408
|
MGAT2
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
|
|
chr16_+_85646923
|
0.414
|
NM_014615
|
KIAA0182
|
KIAA0182
|
|
chr6_+_45390376
|
0.413
|
|
RUNX2
|
runt-related transcription factor 2
|
|
chr17_+_40610905
|
0.412
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
chr16_-_65155965
|
0.410
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
chr17_+_40610940
|
0.408
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
chr10_+_14880335
|
0.408
|
|
HSPA14
|
heat shock 70kDa protein 14
|
|
chr7_-_150946031
|
0.405
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
chr17_+_42634598
|
0.404
|
NM_001466
|
FZD2
|
frizzled family receptor 2
|
|
chr1_-_44820923
|
0.404
|
|
ERI3
|
ERI1 exoribonuclease family member 3
|
|
chrX_-_141293056
|
0.403
|
NM_016249
|
MAGEC2
|
melanoma antigen family C, 2
|
|
chr4_+_140222668
|
0.403
|
NM_057175
|
NAA15
|
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
|
|
chr1_-_148176392
|
0.402
|
|
|
|
|
chr16_+_86544104
|
0.402
|
NM_001451
|
FOXF1
|
forkhead box F1
|
|
chr15_+_74218811
|
0.401
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
chr18_+_9708299
|
0.401
|
|
RAB31
|
RAB31, member RAS oncogene family
|
|
chr15_+_40733302
|
0.398
|
NM_014952
|
BAHD1
|
bromo adjacent homology domain containing 1
|
|
chr11_-_32452358
|
0.398
|
NM_001198551
NM_001198552
|
WT1
|
Wilms tumor 1
|
|
chr13_-_103426130
|
0.398
|
|
C13orf27
|
chromosome 13 open reading frame 27
|
|
chr7_-_140179333
|
0.396
|
NM_001145125
NM_013446
|
MKRN1
|
makorin ring finger protein 1
|
|
chr20_+_53092131
|
0.395
|
NM_018431
|
DOK5
|
docking protein 5
|
|
chr17_+_40610875
|
0.392
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
